Table 4 6-month mortality rates
ELAN-HF score risk group | ELAN-HF cohort | Study cohort (95% CI) | |
|---|---|---|---|
Low ≤ 2 | 3.6% | 10.0% | (0 – 28.8%) |
Intermediate 3—4 | 9.2% | 10.8% | (0 – 23.3%) |
High 5–7 | 23.5% | 29.3% | (13.8 – 41.9%) |
Very high ≥ 8 | 51.1% | 60.0% | (14.5 – 81.3%) |
ELAN-HF score risk group | ELAN-HF cohort | Study cohort (95% CI) | |
|---|---|---|---|
Low ≤ 2 | 3.6% | 10.0% | (0 – 28.8%) |
Intermediate 3—4 | 9.2% | 10.8% | (0 – 23.3%) |
High 5–7 | 23.5% | 29.3% | (13.8 – 41.9%) |
Very high ≥ 8 | 51.1% | 60.0% | (14.5 – 81.3%) |